RecruitingPhase 4NCT07405229
MEdical Treatment in Idiopathic Ventricular Fibrillation Patients
Studying Idiopathic ventricular fibrillation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Bo Gregers Winkel
- Principal Investigator
- Bo G Winkel, MDThe Heart Center, Rigshospitalet
- Intervention
- Beta-blocker treatment group(drug)
- Enrollment
- 218 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2018 – 2035
Study locations (2)
- The Heart Center, Rigshospitalet, Copenhagen, Dr., Denmark
- Odense University Hospital, Odense, Denmark
Collaborators
The Novo Nordisk Foundation · Per Henriksen Foundation · Danish Heart Foundation · RH research funds
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07405229 on ClinicalTrials.govOther trials for Idiopathic ventricular fibrillation
Additional recruiting or active studies for the same condition.